BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 23291310)

  • 1. Cognitive impairment has a strong relation to nonsomatic symptoms of depression in relapsing-remitting multiple sclerosis.
    Sundgren M; Maurex L; Wahlin Å; Piehl F; Brismar T
    Arch Clin Neuropsychol; 2013 Mar; 28(2):144-55. PubMed ID: 23291310
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cognitive impairment and its relation with disease measures in mildly disabled patients with relapsing-remitting multiple sclerosis: baseline results from the Cognitive Impairment in Multiple Sclerosis (COGIMUS) study.
    Patti F; Amato MP; Trojano M; Bastianello S; Tola MR; Goretti B; Caniatti L; Di Monte E; Ferrazza P; Brescia Morra V; Lo Fermo S; Picconi O; Luccichenti G;
    Mult Scler; 2009 Jul; 15(7):779-88. PubMed ID: 19542262
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cognitive impairment differs between primary progressive and relapsing-remitting MS.
    Ruet A; Deloire M; Charré-Morin J; Hamel D; Brochet B
    Neurology; 2013 Apr; 80(16):1501-8. PubMed ID: 23516324
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fatigue and its relationships with cognitive functioning and depression in paediatric multiple sclerosis.
    Goretti B; Portaccio E; Ghezzi A; Lori S; Moiola L; Falautano M; Viterbo R; Patti F; Vecchio R; Pozzilli C; Bianchi V; Cappiello S; Comi G; Trojano M; Amato MP;
    Mult Scler; 2012 Mar; 18(3):329-34. PubMed ID: 21844064
    [TBL] [Abstract][Full Text] [Related]  

  • 5. APOE-epsilon4 is not associated with cognitive impairment in relapsing-remitting multiple sclerosis.
    Portaccio E; Goretti B; Zipoli V; Nacmias B; Stromillo ML; Bartolozzi ML; Siracusa G; Guidi L; Federico A; Sorbi S; De Stefano N; Amato MP
    Mult Scler; 2009 Dec; 15(12):1489-94. PubMed ID: 19965518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Neuropsychology of mildly disabled patients with relapsing-remitting multiple sclerosis].
    Santiago Rolanía O; Guàrdia Olmos J; Arbizu Urdiain T
    Psicothema; 2006 Feb; 18(1):84-7. PubMed ID: 17296014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The psychosocial and cognitive impact of longstanding 'benign' multiple sclerosis.
    Sayao AL; Bueno AM; Devonshire V; Tremlett H;
    Mult Scler; 2011 Nov; 17(11):1375-83. PubMed ID: 21677023
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Event related potential and response time give evidence for a physiological reserve in cognitive functioning in relapsing-remitting multiple sclerosis.
    Sundgren M; Wahlin Å; Maurex L; Brismar T
    J Neurol Sci; 2015 Sep; 356(1-2):107-12. PubMed ID: 26117361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perception of affective prosody in patients at an early stage of relapsing-remitting multiple sclerosis.
    Kraemer M; Herold M; Uekermann J; Kis B; Daum I; Wiltfang J; Berlit P; Diehl RR; Abdel-Hamid M
    J Neuropsychol; 2013 Mar; 7(1):91-106. PubMed ID: 23126275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective decline in information processing in subgroups of multiple sclerosis: an 8-year longitudinal study.
    Bergendal G; Fredrikson S; Almkvist O
    Eur Neurol; 2007; 57(4):193-202. PubMed ID: 17272938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Theory of mind and empathy in patients at an early stage of relapsing remitting multiple sclerosis.
    Kraemer M; Herold M; Uekermann J; Kis B; Wiltfang J; Daum I; Dziobek I; Berlit P; Diehl RR; Abdel-Hamid M
    Clin Neurol Neurosurg; 2013 Jul; 115(7):1016-22. PubMed ID: 23199520
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spectroscopic axonal damage of the right locus coeruleus relates to selective attention impairment in early stage relapsing-remitting multiple sclerosis.
    Gadea M; Martínez-Bisbal MC; Marti-Bonmatí L; Espert R; Casanova B; Coret F; Celda B
    Brain; 2004 Jan; 127(Pt 1):89-98. PubMed ID: 14506072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of immunomodulatory treatment with subcutaneous interferon beta-1a on cognitive decline in mildly disabled patients with relapsing-remitting multiple sclerosis.
    Patti F; Amato MP; Bastianello S; Caniatti L; Di Monte E; Ferrazza P; Goretti B; Gallo P; Morra VB; Lo Fermo S; Picconi O; Tola MR; Trojano M;
    Mult Scler; 2010 Jan; 16(1):68-77. PubMed ID: 19995846
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cognitive and depressive disorders in multiple sclerosis.
    Alajbegović A; Loga N; Tiro N; Alajbegović S; Cindro V; Hozo I
    Acta Clin Croat; 2009 Mar; 48(1):3-8. PubMed ID: 19623864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of cognitive impairment and lesion volumes in multiple sclerosis--a MRI study.
    Yildiz M; Tettenborn B; Radue EW; Bendfeldt K; Borgwardt S
    Clin Neurol Neurosurg; 2014 Dec; 127():54-8. PubMed ID: 25459243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Indices of cognitive dysfunction in relapsing-remitting multiple sclerosis: intra-individual variability, processing speed, and attention network efficiency.
    Wojtowicz M; Omisade A; Fisk JD
    J Int Neuropsychol Soc; 2013 May; 19(5):551-8. PubMed ID: 23425598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quality of life, depression and fatigue in mildly disabled patients with relapsing-remitting multiple sclerosis receiving subcutaneous interferon beta-1a: 3-year results from the COGIMUS (COGnitive Impairment in MUltiple Sclerosis) study.
    Patti F; Amato MP; Trojano M; Bastianello S; Tola MR; Picconi O; Cilia S; Cottone S; Centonze D; Gasperini C;
    Mult Scler; 2011 Aug; 17(8):991-1001. PubMed ID: 21502310
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of neocortical volume changes with cognitive deterioration in relapsing-remitting multiple sclerosis.
    Amato MP; Portaccio E; Goretti B; Zipoli V; Battaglini M; Bartolozzi ML; Stromillo ML; Guidi L; Siracusa G; Sorbi S; Federico A; De Stefano N
    Arch Neurol; 2007 Aug; 64(8):1157-61. PubMed ID: 17698706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cognitive impairment after three decades of multiple sclerosis.
    Smestad C; Sandvik L; Landrø NI; Celius EG
    Eur J Neurol; 2010 Mar; 17(3):499-505. PubMed ID: 20050887
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A longitudinal study on fatigue, depression, and their relation to neurocognition in multiple sclerosis.
    Hildebrandt H; Eling P
    J Clin Exp Neuropsychol; 2014; 36(4):410-7. PubMed ID: 24702275
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.